These loci contained SNPs in or near FGFR2, TNRC9, MAP3K1, LSP1, and H19. Finally, Hunter et al. [33] conducted a two-stage genome-wide association study using 2921 European postmenopausal breast cancer cases and 3214 controls, and identified four intronic FGFR2 SNPs, thereby independently replicating Easton et al.’s finding. This evidence concerns the gene FGFR2 and breast carcinoma.